Abstract
Most human tumors, including colon-cancer tumors, develop in elderly people. One of the significant mutations that cause the development of malignant colon tumors is an activating mutation in the K-ras oncogene. The present study reports the results of a frequency analysis for this mutation in different age groups of colorectal cancer patients in northwest Russia and the connection between this mutation and the most significant clinical factors.
Similar content being viewed by others
References
Gar’kavtseva, R.F., Amosenko, F.A., and Kalinin, V.I., Analysis of Somatic Mutations of gene K-ras at Adenocarcinoma of the Colon and Pancreas, Vestn. Ros. Nauch. Tsentra im. N.N. Blokhina, 2005, vol. 3, no. 4, pp. 16–23.
Dil’man, V.M., Endokrinologicheskaya onkologiya (Endocrinological Oncology), Leningrad: Meditsina, 1974.
Zaridze, D.G., Epidemiological Study of Morphogenetic Relationship between Adenoma and Colon Cancer, Arkh. Pat., 1987, no. 12, pp. 25–31.
Imyanitov, E.N., Kalinovskii, V.P., Knyazev, P.G., et al., Molecular Genetics of Human Tumor, Vopr. Onkol., 1997, vol. 43, no. 1, pp. 95–101.
Imyanitov, E.N., Clinical and Molecular Aspects of Colorectal Cancer: Etiopathogenesis, Prophylactics and Individual Approach to the Therapy, Praktich. Onkol., 2005, vol. 6, no. 2, pp. 65–70.
Imyanitov, E.N. and Khanson, K.P., Molekulyarnaya onkologiya: klinicheskie aspekty (Molecular Oncology: Clinical Aspects), St. Petersburg: MAPO, 2007.
Kantserogenez (Carcinogenesis), Zaridze, D.G., Ed., Moscow: Meditsina, 2004.
Martynyuk, V.V., The Colon Cancer (Morbidity, Mortality, Risk Factors and Screening), in Prakticheskaya onkologiya: Izbr. lektsii (Practical Oncology: Selective Studies), St. Petersburg, 2004.
Mel’nikov, R.A., Kovalev, V.A., Pravosudov, I.V., et al., Polyps and the Colon Cancer, Khirurgiya, 1989, no. 5, pp. 101–102.
Merabishvili, V.M., Zlokachestvennye novoobrazovaniya v mire, Rossii, Sankt-Peterburge (Malignant Neoplasms in Patients of the World, Russia and St. Petersburg), St. Petersburg, 2007.
Prorokov, V.V., Malikhov, A.G., and Knysh, V.I., Contemporary Principles of Diagnostics and Screening of the Colon Cancer, Praktich. Onkol., 2002, no. 10, pp. 77–81.
Rak obodochnoi i pryamoi kishki (Colon and Rectum Cancer), Knysh, V.I., Ed., Moscow: Meditsina, 1997.
Rak tolstoi kishki (The Colon Cancer), Meierkhardt, Dzh. and Sanderz, M., Eds., Moscow: Rid Elsevier, 2009.
Rak u pozhilykh (Cancer in Elderly People), Anisimov, V.N., Moiseenko, V.M., Khanson, K.P., Eds., St. Petersburg: N-L, 2004.
Fedorov, V.D., Therapy of the Colon Polyps, Khirurgiya, 1987, no. 1, pp. 82–86.
AJCC Cancer Staging Handbook 7th ed., Springer Science+Business Media, 2010, 718 p.
Andreyev, H.J., Norman, A.R., and Cunningham, D., Kirsten ras Mutations in Patients with Colorectal Cancer: The Multicenter “RASCAL” Study, J. Natl. Cancer Inst., 1998, vol. 90, no. 9, pp. 675–684.
Bos, J.L., Ras Oncogenes in Human Cancer: A Review, Cancer Res., 1989, vol. 49, pp. 4682–4689.
Brink, M., De Goeij, A.F.P.M., Weijenberg, M.P., et al., K-ras Oncogene Mutations in Sporadic Colorectal Cancer in the Netherlands Cohort Study, Carcinogenesis, 2003, vol. 24, no. 4, pp. 703–710.
Brison, O., Gene Amplification and Tumor Progression, Biochim. Biophys. Acta, 1993, vol. 1155, no. 1, pp. 25–41.
Cancer Incidence in Five Continents, Curado, M.P., et al., Eds., IARC, 2007, vol. 9, 896 p.
Diamandis, E.P., Oncogenes and Tumor Suppressor Genes: New Biochemical Tests, Critical Rev. Clin. Lab. Sci., 1992, vol. 29, nos. 3–4, pp. 269–305.
Di Fiore, F., Blanchard, F., Charbonnier, F., et al., Clinical Relevance of K-RAS Mutation Detection in Metastatic Colorectal Cancer Treated by Cetuximab Plus Chemotherapy, Brit. J. Cancer, 2007, vol. 96, pp. 1166–1169.
DNA Sequencing II: Optimizing Preparation and Cleanup, Kieleczawa, J., Ed., Sudbury MA: Jones and Bartlett Publishers, 2006, pp. 85–98.
Fearon, E.R. and Vogelstein, B., A Genetic Model for Colorectal Tumorigenesis, Cell, 1990, vol. 61, pp. 759–767.
Finkelstein, S.D., Sayegh, R., Christensen, S., and Swalsky, P.A., Genotypic Classification of Colorectal Adenocarcinoma. Biologic Behavior Correlates with K-ras-2 Mutation Type, Cancer, 1993, vol. 71, pp. 3827–3838.
Jass, J.R., Colorectal Adenoma Progression and Genetic Change: Is There a Link?, Ann. Med., 1995, vol. 27, pp. 301–306.
Krtolica, K., Krajnovic, M., Usaj-Knezevic, S., et al., Comethylation of P 16 and MGMT Genes in Colorectal Carcinoma: Correlation with Clinicopathological Features and Prognostic Value, World J. Gastroenterol., 2007, vol. 13, no. 8, pp. 1187–1194.
Lièvre, A., Bachet, J.B., Boige, V., et al., K-RAS Mutations as an Independent Prognostic Factor in Patients with Advanced Colorectal Cancer Treated with Cetuximab, J. Clin. Oncol., 2008, vol. 26, no. 3, pp. 374–379.
Richman, S.D., Seymour, M.T., Chambers, P., et al., K-RAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated with Poor Prognosis but Do not Preclude Benefit from Oxaliplatin or Irinotecan: Results from the MRC FOCUS Trial, J. Clin. Oncol., 2009, vol. 27, no. 35, pp. 5931–5937.
Schimanski, C.C., Zimmermann, T., Schmidtmann, I., et al., K-Ras Mutation Status Correlates with the Expression of VEGFR1, VEGFR2, and PDGFRalpha in Colorectal Cancer, Int. J. Colorectal. Dis., 2010, vol. 25, no. 2, pp. 181–186.
Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., et al., Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer, J. Natl. Cancer Inst., 2009, vol. 101, no. 19, pp. 1308–1324.
Smith, G., Bounds, R., Wolf, H., et al., Activating K-Ras Mutations Outwith “Hotspot” Codons in Sporadic Colorectal Tumors-Implications for Personalized Cancer Medicine, Brit. J. Cancer, 2010, vol. 102, no. 4, pp. 693–703.
Soliman, A.S., Bondy, M.L., El-Badawy, S.A., et al., Contrasting Molecular Pathology of Colorectal Carcinoma in Egyptian and Western Patients, Brit. J. Cancer, 2001, vol. 85, no. 7, pp. 1037–1046.
Vogelstein, B., Fearon, E.R., Hamilton, S.R., et al., Genetic Alterations during Colorectal-Tumor Development, N. Engl. J. Med., 1988, vol. 319, no. 9, pp. 525–532.
Yunxia, Z., Jun, C., Guanshan, Zh., et al., Mutations in Epidermal Growth Factor Receptor and K-ras in Chinese Patients with Colorectal Cancer, BMC Med. Genet., 2010, vol. 11, no. 34, pp. 1–10.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.V. Belyaeva, G.A. Yanus, E.N. Suspitsyn, O.A. Zaitseva, O.S. Yatsuk, A.B. Moiseenko, A.V. Gulyaev, E.N. Imyanitov, 2012, published in Uspekhi Gerontologii, 2012, Vol. 25, No. 1, pp. 72–78.
Rights and permissions
About this article
Cite this article
Belyaeva, A.V., Yanus, G.A., Suspitsyn, E.N. et al. Age-related and clinicopathological features of colorectal cancer associated with K-ras gene status. Adv Gerontol 2, 306–311 (2012). https://doi.org/10.1134/S2079057012040030
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057012040030